An Advanced Decision Support Tool, Opt-IVF for Clinical Ivf Practice
NCT05564702 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 93
Last updated 2023-04-28
Summary
Aim: A Clinical trial to determine the effectiveness of using the proposed decision support tool for each patient's customized optimal drug dosage profile. This will be a two-arm clinical trial involving 200 patients; one arm will undergo superovulation using dosages predicted by the decision support tool while the other arm will undergo current standard treatment. The investigators will compare the outcomes of the two groups of patients in terms of the numbers and percentage of mature follicles retrieved at the end of each cycle, total FSH and HMG dosages used, and the number of required testing days for that cycle. The patients considered will include all ages, with and without PCOS, and low, average, and high responders.
Conditions
Interventions
- OTHER
-
traditional drug treatment
The patients in this arm will be given doctor specified dosage.
- OTHER
-
Opt-IVF predicted dosage
The patients in this arm will be given dosage predicted by Opt-IVF.
Sponsors & Collaborators
-
Akansha Hospital and Research Institute, India
collaborator UNKNOWN -
Stochastic Research Technologies LLC
lead INDUSTRY
Principal Investigators
-
Urmila Diwekar · Stochastic Research Technologies LLC
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- SEQUENTIAL
Eligibility
- Min Age
- 18 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-08
- Primary Completion
- 2023-03-15
- Completion
- 2023-03-15
Countries
- India
Study Locations
More Related Trials
-
Cumulative Pregnancy Rate With Lower and Higher Gonadotropin Dose During IVF Among Poor Responders
NCT05103228 ·Status: COMPLETED ·Phase: NA
-
Cetrotide Treatment Optimization
NCT00866034 ·Status: TERMINATED ·Phase: PHASE4
-
An Observational Study to Evaluate Efficacy, Safety and Clinical Outcomes of Currently Used Pharmaceutical Therapies for Controlled Ovarian Stimulation in Assisted Reproductive Techniques
NCT01149070 ·Status: COMPLETED
-
Efficacy and Safety of Medication Used to Stimulate Ovulation
NCT02715336 ·Status: UNKNOWN ·Phase: PHASE4
-
Cumulative Live Birth After Double Stimulation Protocol Versus Antagonist Protocol for Poor Ovarian Responders
NCT05765968 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Retrospective Study in Chinese Good Prognosis Patients Undergoing Assisted Reproductive Technology (ART) Treatment
NCT02889380 ·Status: COMPLETED
-
Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)
NCT01185704 ·Status: COMPLETED ·Phase: PHASE3
-
Infertility Therapy for Women Age Thirty-eight and Older
NCT00246506 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Observational Study of Biomarkers for a Personalised IVF Treatment
NCT05780632 ·Status: RECRUITING
-
Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVF
NCT03680053 ·Status: TERMINATED ·Phase: NA
-
Comparison of 2 Ovarian Stimulation Protocols for Women With Low Ovarian Reserve
NCT02128360 ·Status: UNKNOWN ·Phase: NA
-
Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF
NCT01058252 ·Status: UNKNOWN
-
The Impact of Personalized Prognostic Counseling on IVF Patient's Experience and Treatment Utilization
NCT06319573 ·Status: RECRUITING ·Phase: NA
-
Synchronization of Follicle Wave Emergence and Ovarian Stimulation
NCT00439829 ·Status: COMPLETED ·Phase: PHASE4
-
Antagonist Protocol in IVF
NCT02335736 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Assess the Patterns of Use of REKOVELLE® in Naïve Women Undergoing In Vitro Fertilisation or Intracytoplasmic Sperm Injection Procedures
NCT03393780 ·Status: COMPLETED
-
Induction of Ovulation Using Clomiphene Citrate and N-acetyl Cysteine Versus Letrozole
NCT03241472 ·Status: COMPLETED ·Phase: PHASE3
-
Role of Inhibin A as Biomarker for Ovarian Response for IVF Treatment
NCT03607409 ·Status: COMPLETED
-
Evaluating the Usability of the Product Kinder System Trial, Home Based Hormone for In-Vitro Fertilization (IVF) Monitoring System.
NCT05634850 ·Status: UNKNOWN
-
IUI vs. IVF/ICSI in Women Aged 38-42 Years: a Prospective Randomized Controlled Trial.
NCT01992731 ·Status: UNKNOWN ·Phase: PHASE4
-
Genetic Variation in Gonadotropin and Gonadotropin Receptor Genes and Suboptimal Response
NCT03007043 ·Status: COMPLETED
-
A Prediction Model and Assisted Decision-making System of Fertilization Disorders
NCT05730764 ·Status: UNKNOWN ·Phase: NA
-
FSH Doser for Controlled Ovarian Stimulation
NCT05948293 ·Status: WITHDRAWN ·Phase: NA
-
Luteal Phase-start Ovarian Stimulation With Corifollitropin Alfa
NCT03555942 ·Status: COMPLETED ·Phase: NA
-
NATural Ovarian Stimulation
NCT02892942 ·Status: COMPLETED ·Phase: PHASE4